Changes	changes	O	O	O	O
in	in	O	O	O	O
depressive	depressive	O	DISEASE	OTHERS	I
status	status	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
topical	topical	O	O	O	O
beta-blockers	beta-blockers	O	O	O	O
.	.	O	O	O	O

Depression	depression	O	DISEASE	OTHERS	I
and	and	O	O	O	O
sexual	sexual	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
have	have	O	O	O	O
been	been	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
topical	topical	O	O	O	O
beta-blockers	beta-blockers	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
performed	performed	O	O	O	O
a	a	O	O	O	O
preliminary	preliminary	O	O	O	O
study	study	O	O	O	O
in	in	O	O	O	O
order	order	O	O	O	O
to	to	O	O	O	O
determine	determine	O	O	O	O
any	any	O	O	O	O
difference	difference	O	O	O	O
between	between	O	O	O	O
a	a	O	O	O	O
non	non	O	O	O	O
selective	selective	O	O	O	O
beta-blocker	beta-blocker	O	O	O	O
(	(	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
and	and	O	O	O	O
a	a	O	O	O	O
selective	selective	O	O	O	O
beta-blocker	beta-blocker	O	O	O	O
(	(	O	O	O	O
betaxolol	betaxolol	O	O	OTHERS	I
)	)	O	O	O	O
regarding	regarding	O	O	O	O
CNS	cns	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
.	.	O	O	O	O

Eight	eight	O	O	O	O
glaucomatous	glaucomatous	O	O	OTHERS	I
patients	patients	O	O	O	O
chronically	chronically	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
0.5%/12h	0.5%/12h	O	O	O	O
,	,	O	O	O	O
suffering	suffering	O	O	O	O
from	from	O	O	O	O
depression	depression	O	DISEASE	OTHERS	I
diagnosed	diagnosed	O	O	O	O
through	through	O	O	O	O
DMS-III-R	dms-iii-r	O	O	O	O
criteria	criteria	O	O	O	O
,	,	O	O	O	O
were	were	O	O	O	O
included	included	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

During	during	O	O	O	O
the	the	O	O	O	O
six-month	six-month	O	O	O	O
follow	follow	O	O	O	O
up	up	O	O	O	O
,	,	O	O	O	O
depression	depression	O	DISEASE	OTHERS	I
was	was	O	O	O	O
quantified	quantified	O	O	O	O
through	through	O	O	O	O
the	the	O	O	O	O
Beck	beck	O	O	O	O
and	and	O	O	O	O
Zung-Conde	zung-conde	O	O	O	O
scales	scales	O	O	O	O
every	every	O	O	O	O
two	two	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
a	a	O	O	O	O
double	double	O	O	O	O
blind	blind	O	O	OTHERS	I
cross-over	cross-over	O	O	O	O
study	study	O	O	O	O
with	with	O	O	O	O
control	control	O	O	O	O
group	group	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
under	under	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
presented	presented	O	O	O	O
higher	higher	O	O	O	O
depression	depression	O	DISEASE	OTHERS	I
values	values	O	O	O	O
measured	measured	O	O	O	O
through	through	O	O	O	O
the	the	O	O	O	O
Beck	beck	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
Zung-Conde	zung-conde	O	O	O	O
scales	scales	O	O	O	O
(	(	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.001	0.001	O	O	O	O
vs	vs	O	O	O	O
control	control	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
betaxolol	betaxolol	O	O	OTHERS	I
could	could	O	O	O	O
be	be	O	O	O	O
less	less	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
depression-inducer	depression-inducer	O	O	O	O
than	than	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
predisposed	predisposed	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

